High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry. / Aichner, F T; Topakian, R; Alberts, M J; Bhatt, D L; Haring, H-P; Hill, M D; Montalescot, G; Goto, S; Touzé, E; Mas, J-L; Steg, P G; Röther, J; Iversen, Helle Klingenberg; REACH Registry Investigators.

In: European Journal of Neurology, Vol. 16, No. 8, 01.08.2009, p. 902-8.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Aichner, FT, Topakian, R, Alberts, MJ, Bhatt, DL, Haring, H-P, Hill, MD, Montalescot, G, Goto, S, Touzé, E, Mas, J-L, Steg, PG, Röther, J, Iversen, HK & REACH Registry Investigators 2009, 'High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry', European Journal of Neurology, vol. 16, no. 8, pp. 902-8. https://doi.org/10.1111/j.1468-1331.2009.02614.x

APA

Aichner, F. T., Topakian, R., Alberts, M. J., Bhatt, D. L., Haring, H-P., Hill, M. D., Montalescot, G., Goto, S., Touzé, E., Mas, J-L., Steg, P. G., Röther, J., Iversen, H. K., & REACH Registry Investigators (2009). High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry. European Journal of Neurology, 16(8), 902-8. https://doi.org/10.1111/j.1468-1331.2009.02614.x

Vancouver

Aichner FT, Topakian R, Alberts MJ, Bhatt DL, Haring H-P, Hill MD et al. High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry. European Journal of Neurology. 2009 Aug 1;16(8):902-8. https://doi.org/10.1111/j.1468-1331.2009.02614.x

Author

Aichner, F T ; Topakian, R ; Alberts, M J ; Bhatt, D L ; Haring, H-P ; Hill, M D ; Montalescot, G ; Goto, S ; Touzé, E ; Mas, J-L ; Steg, P G ; Röther, J ; Iversen, Helle Klingenberg ; REACH Registry Investigators. / High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry. In: European Journal of Neurology. 2009 ; Vol. 16, No. 8. pp. 902-8.

Bibtex

@article{48de0b3256294df395c69883662591b2,
title = "High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry",
abstract = "BACKGROUND AND PURPOSE: Data on current cardiovascular event rates in patients with asymptomatic carotid artery stenosis (ACAS) are sparse. We compared the 1-year outcomes of patients with ACAS > or =70% versus patients without ACAS in an international, prospective cohort of outpatients with or at risk of atherothrombosis. METHODS: The Reduction of Atherothrombosis for Continued Health Registry enrolled patients with either > or =3 atherothrombotic risk factors or established atherothrombotic disease. We investigated the 1-year follow-up data of patients for whom physicians reported presence/absence of ACAS at the time of inclusion. RESULTS: Compared with patients without ACAS (n = 30 329), patients with ACAS (n = 3164) had higher age- and sex-adjusted 1-year rates of transient ischaemic attack (3.51% vs. 1.61%, P <0.0001), non-fatal stroke (2.65% vs. 1.75%, P = 0.0009), fatal stroke (0.49% vs. 0.26%, P = 0.04), cardiovascular death (2.29% vs. 1.52%, P = 0.002), the composite end-point cardiovascular death/myocardial infarction/stroke (6.03% vs. 4.29%, P <0.0001) and bleeding events (1.41% vs. 0.81%, P = 0.002). In patients with ACAS, Cox regression analyses identified history of cerebrovascular ischaemic events as most important predictor of future stroke (HR 3.21, 95% CI 1.82-5.65, P <0.0001). CONCLUSION: Asymptomatic carotid artery stenosis was associated with high 1-year rates of cardiovascular and cerebrovascular ischaemic events. Stroke was powerfully predicted by prior cerebrovascular ischaemic events.",
author = "Aichner, {F T} and R Topakian and Alberts, {M J} and Bhatt, {D L} and H-P Haring and Hill, {M D} and G Montalescot and S Goto and E Touz{\'e} and J-L Mas and Steg, {P G} and J R{\"o}ther and Iversen, {Helle Klingenberg} and Iversen, {Helle Klingenberg}",
note = "Helle Klingenberg Iversen er med i Study Group. Tilf{\o}jet manuelt i PURE",
year = "2009",
month = aug,
day = "1",
doi = "http://dx.doi.org/10.1111/j.1468-1331.2009.02614.x",
language = "English",
volume = "16",
pages = "902--8",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "8",

}

RIS

TY - JOUR

T1 - High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry

AU - Aichner, F T

AU - Topakian, R

AU - Alberts, M J

AU - Bhatt, D L

AU - Haring, H-P

AU - Hill, M D

AU - Montalescot, G

AU - Goto, S

AU - Touzé, E

AU - Mas, J-L

AU - Steg, P G

AU - Röther, J

AU - Iversen, Helle Klingenberg

AU - REACH Registry Investigators

N1 - Helle Klingenberg Iversen er med i Study Group. Tilføjet manuelt i PURE

PY - 2009/8/1

Y1 - 2009/8/1

N2 - BACKGROUND AND PURPOSE: Data on current cardiovascular event rates in patients with asymptomatic carotid artery stenosis (ACAS) are sparse. We compared the 1-year outcomes of patients with ACAS > or =70% versus patients without ACAS in an international, prospective cohort of outpatients with or at risk of atherothrombosis. METHODS: The Reduction of Atherothrombosis for Continued Health Registry enrolled patients with either > or =3 atherothrombotic risk factors or established atherothrombotic disease. We investigated the 1-year follow-up data of patients for whom physicians reported presence/absence of ACAS at the time of inclusion. RESULTS: Compared with patients without ACAS (n = 30 329), patients with ACAS (n = 3164) had higher age- and sex-adjusted 1-year rates of transient ischaemic attack (3.51% vs. 1.61%, P <0.0001), non-fatal stroke (2.65% vs. 1.75%, P = 0.0009), fatal stroke (0.49% vs. 0.26%, P = 0.04), cardiovascular death (2.29% vs. 1.52%, P = 0.002), the composite end-point cardiovascular death/myocardial infarction/stroke (6.03% vs. 4.29%, P <0.0001) and bleeding events (1.41% vs. 0.81%, P = 0.002). In patients with ACAS, Cox regression analyses identified history of cerebrovascular ischaemic events as most important predictor of future stroke (HR 3.21, 95% CI 1.82-5.65, P <0.0001). CONCLUSION: Asymptomatic carotid artery stenosis was associated with high 1-year rates of cardiovascular and cerebrovascular ischaemic events. Stroke was powerfully predicted by prior cerebrovascular ischaemic events.

AB - BACKGROUND AND PURPOSE: Data on current cardiovascular event rates in patients with asymptomatic carotid artery stenosis (ACAS) are sparse. We compared the 1-year outcomes of patients with ACAS > or =70% versus patients without ACAS in an international, prospective cohort of outpatients with or at risk of atherothrombosis. METHODS: The Reduction of Atherothrombosis for Continued Health Registry enrolled patients with either > or =3 atherothrombotic risk factors or established atherothrombotic disease. We investigated the 1-year follow-up data of patients for whom physicians reported presence/absence of ACAS at the time of inclusion. RESULTS: Compared with patients without ACAS (n = 30 329), patients with ACAS (n = 3164) had higher age- and sex-adjusted 1-year rates of transient ischaemic attack (3.51% vs. 1.61%, P <0.0001), non-fatal stroke (2.65% vs. 1.75%, P = 0.0009), fatal stroke (0.49% vs. 0.26%, P = 0.04), cardiovascular death (2.29% vs. 1.52%, P = 0.002), the composite end-point cardiovascular death/myocardial infarction/stroke (6.03% vs. 4.29%, P <0.0001) and bleeding events (1.41% vs. 0.81%, P = 0.002). In patients with ACAS, Cox regression analyses identified history of cerebrovascular ischaemic events as most important predictor of future stroke (HR 3.21, 95% CI 1.82-5.65, P <0.0001). CONCLUSION: Asymptomatic carotid artery stenosis was associated with high 1-year rates of cardiovascular and cerebrovascular ischaemic events. Stroke was powerfully predicted by prior cerebrovascular ischaemic events.

U2 - http://dx.doi.org/10.1111/j.1468-1331.2009.02614.x

DO - http://dx.doi.org/10.1111/j.1468-1331.2009.02614.x

M3 - Journal article

VL - 16

SP - 902

EP - 908

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 8

ER -

ID: 34163875